Eric Faulkner

Insider Reports History

Location
Houston, TX
Signature
/s/ Christopher Downs, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Faulkner:

Company Role Class Num Shares Value Price $ Report Date Ownership
CNS Pharmaceuticals, Inc. Chief Technology Officer Restricted Stock Units 9,500 02 Mar 2026 Direct

Insider Reports Filed by Eric Faulkner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNSP CNS Pharmaceuticals, Inc. 02 Mar 2026 1 $0 4 Chief Technology Officer 04 Mar 2026, 17:02
CNSP CNS Pharmaceuticals, Inc. 02 Mar 2026 0 $0 3 Chief Technology Officer 04 Mar 2026, 17:02